Goodwin Procter advised Asher Biotherapeutics on the deal.Asher Biotherapeutics announced the closing of its Series B financing, which raised $108 million. The financing was led by Wellington…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
